Page last updated: 2024-08-21

quinazolines and Vasculitis

quinazolines has been researched along with Vasculitis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hui, RC; Ko, JH; Shih, YC; Yang, CH1
Ebi, N; Fukusho, R; Sugimoto, Y; Takahashi, Y; Tsuruno, K; Yamaguchi, O1
Fernández-Guarino, M; Gónzalez-López, C; Olasolo, PJ; Pérez-García, B; Ryan, AM1

Reviews

1 review(s) available for quinazolines and Vasculitis

ArticleYear
[A case of cutaneous vasculitis caused by erlotinib treatment and a review of literature].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2011, Volume: 49, Issue:9

    Topics: Aged; Erlotinib Hydrochloride; Female; Humans; Protein Kinase Inhibitors; Quinazolines; Skin Diseases, Vascular; Vasculitis

2011

Other Studies

2 other study(ies) available for quinazolines and Vasculitis

ArticleYear
Necrotizing vasculitis triggered by gefitinib: an unusual clinical presentation.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Mar-01, Volume: 29, Issue:7

    Topics: Antineoplastic Agents; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Follow-Up Studies; Gefitinib; Humans; Immunohistochemistry; Lower Extremity; Lung Neoplasms; Male; Middle Aged; Necrosis; Neoplasm Invasiveness; Neoplasm Staging; Prednisolone; Quinazolines; Risk Assessment; Skin Diseases, Vascular; Treatment Outcome; Vasculitis

2011
Necrotizing vasculitis due to gefitinib (Iressa).
    International journal of dermatology, 2007, Volume: 46, Issue:8

    Topics: Antineoplastic Agents; Drug Eruptions; Gefitinib; Humans; Male; Middle Aged; Quinazolines; Skin; Vasculitis

2007